Ipsen holds Cancer Science symposium

29 March 2009

French drug major Ipsen held its 5th Colloque Medecine et Recherche in the series on Cancer Science in Jaipur, India on the theme "Molecular  Targets of Cancer Therapy."

The meeting united leading experts from both academia and the  pharmaceutical industry, who brought their unique perspective to the  problems inherent in rational drug design. This included two Nobel Prize  winners, Michael Bishop and Harold Varmus, who discovered oncogenes.  Together, the scientists focused on the steps required to design drugs  that target pathways involving genes such as RAS, PI3K and PTEN,  mobilizing the immune system against tumors, and combating resistance to  targeted therapies.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Company News Directory



Companies featured in this story

More ones to watch >




Today's issue

Company Spotlight